InsiderDB
Sign inStart free trial

Cardinal Health (CAH)

Healthcare · Medical - Distribution

6 members of Congress have disclosed 15 trades in Cardinal Health (CAH) since 2020: 13 buys and 2 sales. The most recent was disclosed on Jul 21, 2026. 1 trade was made by members of a committee that oversees Cardinal Health's industry.

Trades disclosed
15
Members trading
6
Buys / sells
13 / 2
Reported value
$262K–$780K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow CAH

What else is happening at CAH

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. CAHLobbying report·Lobbying disclosures

    CAH: third_quarter 2026 lobbying report

    Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to prov

    Public: Oct 20, 2026, 1:54 PM EDTOriginal source ↗
  2. CAHLobbying report·Lobbying disclosures

    CAH: third_quarter 2026 lobbying report

    General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs Supply chain issues affecting the pharmaceutical industry

    Public: Oct 16, 2026, 3:29 PM EDTOriginal source ↗
  3. CAHLobbying report·Lobbying disclosures

    CAH: second_quarter 2026 lobbying report

    Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preservin

    Public: Jul 20, 2026, 10:07 AM EDTOriginal source ↗
  4. CAHLobbying report·Lobbying disclosures

    CAH: second_quarter 2026 lobbying report

    Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues

    Public: Jul 20, 2026, 9:58 AM EDTOriginal source ↗
  5. CAHLobbying report·Lobbying disclosures

    CAH: second_quarter 2026 lobbying report

    General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs

    Public: Jul 16, 2026, 2:26 PM EDTOriginal source ↗

Committee overlaps

Trades by members of a committee that oversees Cardinal Health's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded CAH

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.